Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabeticdb/dbmice
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 113 (2), 65-75
- https://doi.org/10.1080/13813450701422617
Abstract
The aim of this study was to determine the biochemical mechanism(s) responsible for enhanced FA utilization (oxidation and esterification) by perfused hearts from type 2 diabetic db/db mice. The plasma membrane content of fatty acid transporters FAT/CD36 and FABPpm was elevated in db/db hearts. Mitochondrial mechanisms that could contribute to elevated rates of FA oxidation were also examined. Carnitine palmitoyl transferase-1 activity was unchanged in mitochondria from db/db hearts, and sensitivity to inhibition by malonyl-CoA was unchanged. Malonyl-CoA content was elevated and AMP kinase activity was decreased in db/db hearts, opposite to what would be expected in hearts exhibiting elevated rates of FA oxidation. Uncoupling protein-3 expression was unchanged in mitochondria from db/db hearts. Therefore, enhanced FA utilization in db/db hearts is most likely due to increased FA uptake caused by increased plasma membrane content of FA transporters; the mitochondrial mechanisms examined do not contribute to elevated FA oxidation observed in db/db hearts.Keywords
This publication has 59 references indexed in Scilit:
- Reduced Mitochondrial Oxidative Capacity and Increased Mitochondrial Uncoupling Impair Myocardial Energetics in ObesityCirculation, 2005
- Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3Cell Metabolism, 2005
- Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidationThe FASEB Journal, 2005
- Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36The FASEB Journal, 2004
- Treatment of type 2 diabeticdb/dbmice with a novel PPARγ agonist improves cardiac metabolism but not contractile functionAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Regulation of CPT I activity in intermyofibrillar and subsarcolemmal mitochondria from human and rat skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Age-Dependent Changes in Metabolism, Contractile Function, and Ischemic Sensitivity in Hearts From db/db MiceDiabetes, 2003
- Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-α activatorAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2000
- Effect of endurance training on mRNA expression of uncoupling proteins 1, 2, and 3 in the ratThe FASEB Journal, 1998